Richard E. Champlin

Statistics

Publications

722

Citations

71.2K

H-Index

144

Active since

1981

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Medical College of Wisconsin

Memorial Sloan Kettering Cancer Center

Baylor College of Medicine

University of California, Los Angeles

Richard E. Champlin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and stem cell transplantation.

ORCID

Publications per year

1981–2025

722

Publications

722

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

Robert H. Collins, Ofer Shpilberg, William R. Drobyski et al. · Journal of Clinical Oncology · 1997 · 1.3K citations

Medicine, Hematology, Immunology +8

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt, Elihu H. Estey, Maher Albitar et al. · Blood · 1997 · 1.2K citations · Full text

Medicine, Hematology, Oncology +16

Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia

Mary J. Laughlin, Mary Eapen, Pablo Rubinstein et al. · New England Journal of Medicine · 2004 · 1.1K citations · Full text

Medicine, Hematology, Immunology +17

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

Issa F. Khouri, Michael J. Keating, M Körbling et al. · Journal of Clinical Oncology · 1998 · 927 citations

Medicine, Immunology, Oncology +17

1–5 of 722